Russia Launching World’s 1st Coronavirus Vaccine; Serum Institute’s Covid-19 Vaccine Coming By 2020-End

With the coronavirus pandemic intensifying on a daily basis, thereby enveloping an increasing number of people, scientists and medical expert teams are pushing the boundaries and accelerating their efforts to land up with a successful fit for the COVID-19 vaccine.

In this progression of vaccines to be worked upon and released, Russia seems to be leading as the first country to launch its Covid-19 vaccine.

Russia will be registering its coronavirus vaccine this week on August 12, 2020, according to Deputy Health Minister Oleg Gridnev.

Russia’s 1^st COVID Vaccine to be Registered this Week

The urgency of the Covid-19 vaccine, is the peak need of the hour.

There are, as of now, over 160 candidates in the race of developing the 1^st successful vaccine, all at different stages of trials.

Of these, 27 candidates have successfully made it to the human trial level.

Speaking of Russia, its vaccine is developed by the country’s Gamaleya National Research Centre and the Russian Defence Ministry.

A Brief Into this Vaccine

• The vector candidate of Russia’s vaccine is an adenovirus-based viral vector vaccine, integrated with the protein of SARS-CoV-2 virus, which induces an immune response in the body.
• The scientists and medical experts involved in the vaccine production informed that the particles, which cannot reproduce, are not considered alive.
• This vaccine created by the Russians, cannot multiply the coronavirus particles in the vaccine, thus they cannot harm the body.

When is the Vaccine Anticipated to Release?

While the vaccine is to be registered on Aug 12, the clinical trials had already begun on June 18, which included 38 volunteers.

On their discharge on July 15, it was reported that all 15 candidates developed immunity. The send batch was admitted on July 20.

A Russian agency has reported that the country is in the initial stage of planning serial production of the vaccine by September.

SII as the Foremost Runner in Developing the 1^st Covid Vaccine

Serum Institute of India, in an agreement with Gavi, The Vaccine Alliance as well as the US-based Bill and Melinda Gates Foundation will be developing 10 crore doses of a promising Covid vaccine.

The Bill & Melinda Gates Foundation will help the SII to rapidly manufacture the 10 crore doses of vaccines, developed by the University of Oxford-AstraZeneca and Novavax.

It is anticipated to be ready by December.